Literature DB >> 7679943

Effect of azelastine on substance P content in bronchoalveolar and nasal lavage fluids of patients with allergic asthma.

K Nieber1, C Baumgarten, R Rathsack, J Furkert, E Laake, S Müller, G Kunkel.   

Abstract

The study was carried out to investigate the effect of azelastine on the Substance P (SP) concentration in bronchoalveolar (BAL) and nasal (NAL) lavage obtained from atopic grass pollen asthmatics and non-atopic healthy subjects. In BAL and NAL fluids there was a significant elevation in the baseline concentration of SP between asthmatics and volunteers. Allergen provocation induced a rise of SP in BAL and NAL in asthmatics, but not in volunteers. Azelastine pre-treatment resulted in a significant reduction of SP in baseline concentration of SP in BAL and NAL from asthmatics. An elevation of SP in BAL or NAL fluids after allergen provocation was not seen in asthmatics pretreated with azelastine. Azelastine did not influence the SP concentration in BAL and NAL of volunteers.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7679943     DOI: 10.1111/j.1365-2222.1993.tb02486.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  7 in total

1.  Substance P downregulates expression of the high affinity IgE receptor (FcepsilonRI) by human mast cells.

Authors:  Christine McCary; Brian P Tancowny; Adriana Catalli; Leslie C Grammer; Kathleen E Harris; Robert P Schleimer; Marianna Kulka
Journal:  J Neuroimmunol       Date:  2010-02-01       Impact factor: 3.478

2.  Neurokinin A is the predominant tachykinin in human bronchoalveolar lavage fluid in normal and asthmatic subjects.

Authors:  L G Heaney; L J Cross; L P McGarvey; K D Buchanan; M Ennis; C Shaw
Journal:  Thorax       Date:  1998-05       Impact factor: 9.139

3.  A clinical pharmacokinetic study comparing two azelastine hydrochloride nasal formulations in a single-dose design.

Authors:  Daniel Du; Darren Targett; Erhard Stolberg; Alessandra Canali
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2013-05-17       Impact factor: 2.441

4.  Eosinophils increase airway sensory nerve density in mice and in human asthma.

Authors:  Matthew G Drake; Gregory D Scott; Emily D Blum; Katherine M Lebold; Zhenying Nie; James J Lee; Allison D Fryer; Richard W Costello; David B Jacoby
Journal:  Sci Transl Med       Date:  2018-09-05       Impact factor: 17.956

Review 5.  Neuroimmune Pathophysiology in Asthma.

Authors:  Gandhi F Pavón-Romero; Nancy Haydée Serrano-Pérez; Lizbeth García-Sánchez; Fernando Ramírez-Jiménez; Luis M Terán
Journal:  Front Cell Dev Biol       Date:  2021-05-13

6.  Effectiveness of twice daily azelastine nasal spray in patients with seasonal allergic rhinitis.

Authors:  Friedrich Horak
Journal:  Ther Clin Risk Manag       Date:  2008-10       Impact factor: 2.423

7.  The role of antihistamines in the treatment of vasomotor rhinitis.

Authors:  Phil Lieberman
Journal:  World Allergy Organ J       Date:  2009-08-15       Impact factor: 4.084

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.